- Home/
- Article /
- PMT13, a pyrimidone analogue of thiazolidinedione improves insulin resistance-associated disorders in animal models of type 2 diabetes.
Full Author : ['Chakrabarti, R', 'Vikramadithyan, R K', 'Kumar, M Prem', 'Kumar, S K B', 'Mamidi, N V S', 'Misra, P', 'Suresh, J', 'Hiriyan, J', 'Rao, C S', 'Rajagopalan, R']
Journal Title : Diabetes, obesity & metabolism
Chapter : Section3
Journal Year : 2002
Cited by : Not Available
AIM: To evaluate the antidiabetic and hypolipidaemic potential of a novel thiazolidinedione, PMT13, in different animal models of insulin resistance. METHODS: PPAR transactivation study was performed in HEK293T cells using ligand binding domains of PPARal.....
Keywords : ["thiazolidinedione improve insulin resistanceassociate disorder", "type diabetes", "pyrimidone analogue", "animal model"]